Recombinant Factor VIII
The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More
1 Human Alpha1-Proteinase Inhibitor Market Overview 1.1 Product Overview and Scope of Human Alpha1-Proteinase Inhibitor 1.2 Human Alpha1-Proteinase Inhibitor Segment by Type 1.2.1 Global Human Alpha1-Proteinase Inhibitor Sales Growth Rate Comparison by Type (2022-2028) 1.2.2 0.5g 1.2.3 1g 1.3 Human Alpha1-Proteinase Inhibitor Segment by Application 1.3.1 Global Human Alpha1-Proteinase Inhibitor Sales Comparison by Application: (2022-2028) 1.3.2 Hospital 1.3.3 Pharmacy 1.4 Global Human Alpha1-Proteinase Inhibitor Market Size Estimates and Forecasts 1.4.1 Global Human Alpha1-Proteinase Inhibitor Revenue 2017-2028 1.4.2 Global Human Alpha1-Proteinase Inhibitor Sales 2017-2028 1.4.3 Human Alpha1-Proteinase Inhibitor Market Size by Region: 2017 Versus 2021 Versus 2028 2 Human Alpha1-Proteinase Inhibitor Market Competition by Manufacturers 2.1 Global Human Alpha1-Proteinase Inhibitor Sales Market Share by Manufacturers (2017-2022) 2.2 Global Human Alpha1-Proteinase Inhibitor Revenue Market Share by Manufacturers (2017-2022) 2.3 Global Human Alpha1-Proteinase Inhibitor Average Price by Manufacturers (2017-2022) 2.4 Manufacturers Human Alpha1-Proteinase Inhibitor Manufacturing Sites, Area Served, Product Type 2.5 Human Alpha1-Proteinase Inhibitor Market Competitive Situation and Trends 2.5.1 Human Alpha1-Proteinase Inhibitor Market Concentration Rate 2.5.2 The Global Top 5 and Top 10 Largest Human Alpha1-Proteinase Inhibitor Players Market Share by Revenue 2.5.3 Global Human Alpha1-Proteinase Inhibitor Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Human Alpha1-Proteinase Inhibitor Retrospective Market Scenario by Region 3.1 Global Human Alpha1-Proteinase Inhibitor Retrospective Market Scenario in Sales by Region: 2017-2022 3.2 Global Human Alpha1-Proteinase Inhibitor Retrospective Market Scenario in Revenue by Region: 2017-2022 3.3 North America Human Alpha1-Proteinase Inhibitor Market Facts & Figures by Country 3.3.1 North America Human Alpha1-Proteinase Inhibitor Sales by Country 3.3.2 North America Human Alpha1-Proteinase Inhibitor Revenue by Country 3.3.3 United States 3.3.4 Canada 3.3.3 Mexico 3.4 Europe Human Alpha1-Proteinase Inhibitor Market Facts & Figures by Country 3.4.1 Europe Human Alpha1-Proteinase Inhibitor Sales by Country 3.4.2 Europe Human Alpha1-Proteinase Inhibitor Revenue by Country 3.4.3 Germany 3.4.4 France 3.4.5 UK 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Human Alpha1-Proteinase Inhibitor Market Facts & Figures by Region 3.5.1 Asia Pacific Human Alpha1-Proteinase Inhibitor Sales by Region 3.5.2 Asia Pacific Human Alpha1-Proteinase Inhibitor Revenue by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 China Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.6 Latin America Human Alpha1-Proteinase Inhibitor Market Facts & Figures by Country 3.6.1 Latin America Human Alpha1-Proteinase Inhibitor Sales by Country 3.6.2 Latin America Human Alpha1-Proteinase Inhibitor Revenue by Country 3.6.3 Mexico 3.6.4 Brazil 3.6.5 Argentina 3.7 Middle East and Africa Human Alpha1-Proteinase Inhibitor Market Facts & Figures by Country 3.7.1 Middle East and Africa Human Alpha1-Proteinase Inhibitor Sales by Country 3.7.2 Middle East and Africa Human Alpha1-Proteinase Inhibitor Revenue by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 UAE 4 Global Human Alpha1-Proteinase Inhibitor Historic Market Analysis by Type 4.1 Global Human Alpha1-Proteinase Inhibitor Sales Market Share by Type (2017-2022) 4.2 Global Human Alpha1-Proteinase Inhibitor Revenue Market Share by Type (2017-2022) 4.3 Global Human Alpha1-Proteinase Inhibitor Price by Type (2017-2022) 5 Global Human Alpha1-Proteinase Inhibitor Historic Market Analysis by Application 5.1 Global Human Alpha1-Proteinase Inhibitor Sales Market Share by Application (2017-2022) 5.2 Global Human Alpha1-Proteinase Inhibitor Revenue Market Share by Application (2017-2022) 5.3 Global Human Alpha1-Proteinase Inhibitor Price by Application (2017-2022) 6 Key Companies Profiled 6.1 Takeda 6.1.1 Takeda Corporation Information 6.1.2 Takeda Description and Business Overview 6.1.3 Takeda Human Alpha1-Proteinase Inhibitor Sales, Revenue and Gross Margin (2017-2022) 6.1.4 Takeda Human Alpha1-Proteinase Inhibitor Product Portfolio 6.1.5 Takeda Recent Developments/Updates 6.2 Kamada 6.2.1 Kamada Corporation Information 6.2.2 Kamada Description and Business Overview 6.2.3 Kamada Human Alpha1-Proteinase Inhibitor Sales, Revenue and Gross Margin (2017-2022) 6.2.4 Kamada Human Alpha1-Proteinase Inhibitor Product Portfolio 6.2.5 Kamada Recent Developments/Updates 6.3 Talecris Biotherapeutics 6.3.1 Talecris Biotherapeutics Corporation Information 6.3.2 Talecris Biotherapeutics Description and Business Overview 6.3.3 Talecris Biotherapeutics Human Alpha1-Proteinase Inhibitor Sales, Revenue and Gross Margin (2017-2022) 6.3.4 Talecris Biotherapeutics Human Alpha1-Proteinase Inhibitor Product Portfolio 6.3.5 Talecris Biotherapeutics Recent Developments/Updates 6.4 CSL Behring 6.4.1 CSL Behring Corporation Information 6.4.2 CSL Behring Description and Business Overview 6.4.3 CSL Behring Human Alpha1-Proteinase Inhibitor Sales, Revenue and Gross Margin (2017-2022) 6.4.4 CSL Behring Human Alpha1-Proteinase Inhibitor Product Portfolio 6.4.5 CSL Behring Recent Developments/Updates 7 Human Alpha1-Proteinase Inhibitor Manufacturing Cost Analysis 7.1 Human Alpha1-Proteinase Inhibitor Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Human Alpha1-Proteinase Inhibitor 7.4 Human Alpha1-Proteinase Inhibitor Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Human Alpha1-Proteinase Inhibitor Distributors List 8.3 Human Alpha1-Proteinase Inhibitor Customers 9 Human Alpha1-Proteinase Inhibitor Market Dynamics 9.1 Human Alpha1-Proteinase Inhibitor Industry Trends 9.2 Human Alpha1-Proteinase Inhibitor Market Drivers 9.3 Human Alpha1-Proteinase Inhibitor Market Challenges 9.4 Human Alpha1-Proteinase Inhibitor Market Restraints 10 Global Market Forecast 10.1 Human Alpha1-Proteinase Inhibitor Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Human Alpha1-Proteinase Inhibitor by Type (2023-2028) 10.1.2 Global Forecasted Revenue of Human Alpha1-Proteinase Inhibitor by Type (2023-2028) 10.2 Human Alpha1-Proteinase Inhibitor Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Human Alpha1-Proteinase Inhibitor by Application (2023-2028) 10.2.2 Global Forecasted Revenue of Human Alpha1-Proteinase Inhibitor by Application (2023-2028) 10.3 Human Alpha1-Proteinase Inhibitor Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Human Alpha1-Proteinase Inhibitor by Region (2023-2028) 10.3.2 Global Forecasted Revenue of Human Alpha1-Proteinase Inhibitor by Region (2023-2028) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer
List of Tables Table 1. Global Human Alpha1-Proteinase Inhibitor Sales Growth Rate Comparison by Type (2022-2028) & (MT) & (US$ Million) Table 2. Global Human Alpha1-Proteinase Inhibitor Sales Growth Rate Comparison by Application (2022-2028) & (MT) & (US$ Million) Table 3. Global Human Alpha1-Proteinase Inhibitor Market Size by Region (US$ Million) (2017 VS 2021 VS 2028) Table 4. Global Human Alpha1-Proteinase Inhibitor Market Competitive Situation by Manufacturers in 2021 Table 5. Global Human Alpha1-Proteinase Inhibitor Sales (MT) of Key Manufacturers (2017-2022) Table 6. Global Human Alpha1-Proteinase Inhibitor Sales Market Share by Manufacturers (2017-2022) Table 7. Global Human Alpha1-Proteinase Inhibitor Revenue (US$ Million) by Manufacturers (2017-2022) Table 8. Global Human Alpha1-Proteinase Inhibitor Revenue Share by Manufacturers (2017-2022) Table 9. Global Market Human Alpha1-Proteinase Inhibitor Average Price (USD/Kg) of Key Manufacturers (2017-2022) Table 10. Manufacturers Human Alpha1-Proteinase Inhibitor Manufacturing Sites and Area Served Table 11. Manufacturers Human Alpha1-Proteinase Inhibitor Product Type Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Human Alpha1-Proteinase Inhibitor by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Alpha1-Proteinase Inhibitor as of 2021) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Human Alpha1-Proteinase Inhibitor Sales by Region (2017-2022) & (MT) Table 16. Global Human Alpha1-Proteinase Inhibitor Sales Market Share by Region (2017-2022) Table 17. Global Human Alpha1-Proteinase Inhibitor Revenue by Region (2017-2022) & (US$ Million) Table 18. Global Human Alpha1-Proteinase Inhibitor Revenue Market Share by Region (2017-2022) Table 19. North America Human Alpha1-Proteinase Inhibitor Sales by Country (2017-2022) & (MT) Table 20. North America Human Alpha1-Proteinase Inhibitor Sales Market Share by Country (2017-2022) Table 21. North America Human Alpha1-Proteinase Inhibitor Revenue by Country (2017-2022) & (US$ Million) Table 22. North America Human Alpha1-Proteinase Inhibitor Revenue Market Share by Country (2017-2022) Table 23. Europe Human Alpha1-Proteinase Inhibitor Sales by Country (2017-2022) & (MT) Table 24. Europe Human Alpha1-Proteinase Inhibitor Sales Market Share by Country (2017-2022) Table 25. Europe Human Alpha1-Proteinase Inhibitor Revenue by Country (2017-2022) & (US$ Million) Table 26. Europe Human Alpha1-Proteinase Inhibitor Revenue Market Share by Country (2017-2022) Table 27. Asia Pacific Human Alpha1-Proteinase Inhibitor Sales by Region (2017-2022) & (MT) Table 28. Asia Pacific Human Alpha1-Proteinase Inhibitor Sales Market Share by Region (2017-2022) Table 29. Asia Pacific Human Alpha1-Proteinase Inhibitor Revenue by Region (2017-2022) & (US$ Million) Table 30. Asia Pacific Human Alpha1-Proteinase Inhibitor Revenue Market Share by Region (2017-2022) Table 31. Latin America Human Alpha1-Proteinase Inhibitor Sales by Country (2017-2022) & (MT) Table 32. Latin America Human Alpha1-Proteinase Inhibitor Sales Market Share by Country (2017-2022) Table 33. Latin America Human Alpha1-Proteinase Inhibitor Revenue by Country (2017-2022) & (US$ Million) Table 34. Latin America Human Alpha1-Proteinase Inhibitor Revenue Market Share by Country (2017-2022) Table 35. Middle East and Africa Human Alpha1-Proteinase Inhibitor Sales by Country (2017-2022) & (MT) Table 36. Middle East and Africa Human Alpha1-Proteinase Inhibitor Sales Market Share by Country (2017-2022) Table 37. Middle East and Africa Human Alpha1-Proteinase Inhibitor Revenue by Country (2017-2022) & (US$ Million) Table 38. Middle East and Africa Human Alpha1-Proteinase Inhibitor Revenue Market Share by Country (2017-2022) Table 39. Global Human Alpha1-Proteinase Inhibitor Sales by Type (2017-2022) & (MT) Table 40. Global Human Alpha1-Proteinase Inhibitor Sales Market Share by Type (2017-2022) Table 41. Global Human Alpha1-Proteinase Inhibitor Revenue by Type (2017-2022) & (US$ Million) Table 42. Global Human Alpha1-Proteinase Inhibitor Revenue Share by Type (2017-2022) Table 43. Global Human Alpha1-Proteinase Inhibitor Price by Type (2017-2022) & (USD/Kg) Table 44. Global Human Alpha1-Proteinase Inhibitor Sales (MT) by Application (2017-2022) Table 45. Global Human Alpha1-Proteinase Inhibitor Sales Market Share by Application (2017-2022) Table 46. Global Human Alpha1-Proteinase Inhibitor Revenue by Application (2017-2022) & (US$ Million) Table 47. Global Human Alpha1-Proteinase Inhibitor Revenue Share by Application (2017-2022) Table 48. Global Human Alpha1-Proteinase Inhibitor Price by Application (2017-2022) & (USD/Kg) Table 49. Takeda Corporation Information Table 50. Takeda Description and Business Overview Table 51. Takeda Human Alpha1-Proteinase Inhibitor Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022) Table 52. Takeda Human Alpha1-Proteinase Inhibitor Product Table 53. Takeda Recent Developments/Updates Table 54. Kamada Corporation Information Table 55. Kamada Description and Business Overview Table 56. Kamada Human Alpha1-Proteinase Inhibitor Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022) Table 57. Kamada Human Alpha1-Proteinase Inhibitor Product Table 58. Kamada Recent Developments/Updates Table 59. Talecris Biotherapeutics Corporation Information Table 60. Talecris Biotherapeutics Description and Business Overview Table 61. Talecris Biotherapeutics Human Alpha1-Proteinase Inhibitor Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022) Table 62. Talecris Biotherapeutics Human Alpha1-Proteinase Inhibitor Product Table 63. Talecris Biotherapeutics Recent Developments/Updates Table 64. CSL Behring Corporation Information Table 65. CSL Behring Description and Business Overview Table 66. CSL Behring Human Alpha1-Proteinase Inhibitor Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022) Table 67. CSL Behring Human Alpha1-Proteinase Inhibitor Product Table 68. CSL Behring Recent Developments/Updates Table 69. Production Base and Market Concentration Rate of Raw Material Table 70. Key Suppliers of Raw Materials Table 71. Human Alpha1-Proteinase Inhibitor Distributors List Table 72. Human Alpha1-Proteinase Inhibitor Customers List Table 73. Human Alpha1-Proteinase Inhibitor Market Trends Table 74. Human Alpha1-Proteinase Inhibitor Market Drivers Table 75. Human Alpha1-Proteinase Inhibitor Market Challenges Table 76. Human Alpha1-Proteinase Inhibitor Market Restraints Table 77. Global Human Alpha1-Proteinase Inhibitor Sales Forecast by Type (2023-2028) & (MT) Table 78. Global Human Alpha1-Proteinase Inhibitor Sales Market Share Forecast by Type (2023-2028) Table 79. Global Human Alpha1-Proteinase Inhibitor Revenue Forecast by Type (2023-2028) & (US$ Million) Table 80. Global Human Alpha1-Proteinase Inhibitor Revenue Market Share Forecast by Type (2023-2028) Table 81. Global Human Alpha1-Proteinase Inhibitor Sales Forecast by Application (2023-2028) & (MT) Table 82. Global Human Alpha1-Proteinase Inhibitor Sales Market Share Forecast by Application (2023-2028) Table 83. Global Human Alpha1-Proteinase Inhibitor Revenue Forecast by Application (2023-2028) & (US$ Million) Table 84. Global Human Alpha1-Proteinase Inhibitor Revenue Market Share Forecast by Application (2023-2028) Table 85. Global Human Alpha1-Proteinase Inhibitor Sales Forecast by Region (2023-2028) & (MT) Table 86. Global Human Alpha1-Proteinase Inhibitor Sales Market Share Forecast by Region (2023-2028) Table 87. Global Human Alpha1-Proteinase Inhibitor Revenue Forecast by Region (2023-2028) & (US$ Million) Table 88. Global Human Alpha1-Proteinase Inhibitor Revenue Market Share Forecast by Region (2023-2028) Table 89. Research Programs/Design for This Report Table 90. Key Data Information from Secondary Sources Table 91. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Human Alpha1-Proteinase Inhibitor Figure 2. Global Human Alpha1-Proteinase Inhibitor Market Share by Type in 2021 & 2028 Figure 3. 0.5g Product Picture Figure 4. 1g Product Picture Figure 5. Global Human Alpha1-Proteinase Inhibitor Market Share by Application in 2021 & 2028 Figure 6. Hospital Figure 7. Pharmacy Figure 8. Global Human Alpha1-Proteinase Inhibitor Revenue, (US$ Million), 2017 VS 2021 VS 2028 Figure 9. Global Human Alpha1-Proteinase Inhibitor Market Size (2017-2028) & (US$ Million) Figure 10. Global Human Alpha1-Proteinase Inhibitor Sales (2017-2028) & (MT) Figure 11. Human Alpha1-Proteinase Inhibitor Sales Share by Manufacturers in 2021 Figure 12. Global Human Alpha1-Proteinase Inhibitor Revenue Share by Manufacturers in 2021 Figure 13. The Global 5 and 10 Largest Human Alpha1-Proteinase Inhibitor Players: Market Share by Revenue in 2021 Figure 14. Human Alpha1-Proteinase Inhibitor Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021 Figure 15. Global Human Alpha1-Proteinase Inhibitor Sales Market Share by Region (2017-2022) Figure 16. Global Human Alpha1-Proteinase Inhibitor Sales Market Share by Region in 2021 Figure 17. Global Human Alpha1-Proteinase Inhibitor Revenue Market Share by Region (2017-2022) Figure 18. Global Human Alpha1-Proteinase Inhibitor Revenue Market Share by Region in 2021 Figure 19. United States Human Alpha1-Proteinase Inhibitor Revenue Growth Rate (2017-2022) & (US$ Million) Figure 20. Canada Human Alpha1-Proteinase Inhibitor Revenue Growth Rate (2017-2022) & (US$ Million) Figure 21. Mexico Human Alpha1-Proteinase Inhibitor Revenue Growth Rate (2017-2022) & (US$ Million) Figure 22. Germany Human Alpha1-Proteinase Inhibitor Revenue Growth Rate (2017-2022) & (US$ Million) Figure 23. France Human Alpha1-Proteinase Inhibitor Revenue Growth Rate (2017-2022) & (US$ Million) Figure 24. UK Human Alpha1-Proteinase Inhibitor Revenue Growth Rate (2017-2022) & (US$ Million) Figure 25. Italy Human Alpha1-Proteinase Inhibitor Revenue Growth Rate (2017-2022) & (US$ Million) Figure 26. Russia Human Alpha1-Proteinase Inhibitor Revenue Growth Rate (2017-2022) & (US$ Million) Figure 27. China Human Alpha1-Proteinase Inhibitor Revenue Growth Rate (2017-2022) & (US$ Million) Figure 28. Japan Human Alpha1-Proteinase Inhibitor Revenue Growth Rate (2017-2022) & (US$ Million) Figure 29. South Korea Human Alpha1-Proteinase Inhibitor Revenue Growth Rate (2017-2022) & (US$ Million) Figure 30. India Human Alpha1-Proteinase Inhibitor Revenue Growth Rate (2017-2022) & (US$ Million) Figure 31. Australia Human Alpha1-Proteinase Inhibitor Revenue Growth Rate (2017-2022) & (US$ Million) Figure 32. China Taiwan Human Alpha1-Proteinase Inhibitor Revenue Growth Rate (2017-2022) & (US$ Million) Figure 33. Indonesia Human Alpha1-Proteinase Inhibitor Revenue Growth Rate (2017-2022) & (US$ Million) Figure 34. Thailand Human Alpha1-Proteinase Inhibitor Revenue Growth Rate (2017-2022) & (US$ Million) Figure 35. Malaysia Human Alpha1-Proteinase Inhibitor Revenue Growth Rate (2017-2022) & (US$ Million) Figure 36. Mexico Human Alpha1-Proteinase Inhibitor Revenue Growth Rate (2017-2022) & (US$ Million) Figure 37. Brazil Human Alpha1-Proteinase Inhibitor Revenue Growth Rate (2017-2022) & (US$ Million) Figure 38. Argentina Human Alpha1-Proteinase Inhibitor Revenue Growth Rate (2017-2022) & (US$ Million) Figure 39. Turkey Human Alpha1-Proteinase Inhibitor Revenue Growth Rate (2017-2022) & (US$ Million) Figure 40. Saudi Arabia Human Alpha1-Proteinase Inhibitor Revenue Growth Rate (2017-2022) & (US$ Million) Figure 41. UAE Human Alpha1-Proteinase Inhibitor Revenue Growth Rate (2017-2022) & (US$ Million) Figure 42. Sales Market Share of Human Alpha1-Proteinase Inhibitor by Type (2017-2022) Figure 43. Manufacturing Cost Structure of Human Alpha1-Proteinase Inhibitor Figure 44. Manufacturing Process Analysis of Human Alpha1-Proteinase Inhibitor Figure 45. Human Alpha1-Proteinase Inhibitor Industrial Chain Analysis Figure 46. Channels of Distribution Figure 47. Distributors Profiles Figure 48. Bottom-up and Top-down Approaches for This Report Figure 49. Data Triangulation Figure 50. Key Executives Interviewed
Takeda Kamada Talecris Biotherapeutics CSL Behring
The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More
The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More
The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More
The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More